Clearwater has advised Parquest Capital and the shareholders of 5 Santé , a major French player in post‐acute care private clinics specialised in the rehabilitation of chronic patients, on the group’s disposal to Korian. The management also sold its shares but remains involved in the group’s development within Korian.
Located in Perpignan, 5 Santé was founded in 2015 through the purchase of four transition care clinics (TCC), specialised in chronic diseases, by the management and the private equity fund Parquest Capital. Today, the group operates six specialised clinics, totalling 594 beds and places. The company have clinics in Auvergne-Rhône-Alpes and Occitanie and treats nearly 8,000 patients annually. In 2019, 5 Santé employed c. 500 people and generated a turnover of c. €44m.
5 Santé is a leading French player in patients with chronic diseases rehabilitation (pulmonology, cardiology, neurology and addictology). Over the last five years, the 5 Santé group capitalised on its know-how to develop its core activity, to acquire and integrate two transition care clinics in Auvergne-Rhône-Alpes, and to work on the development of new kinds of chronic patients’ support.
Korian, is the European leader in dependent elderly care, listed on the NYSE Euronext regulated market in Paris. With 850 establishments and healthcare networks covering four activities (medicalised nursing homes, specialised clinics, non-medical services homes and homecare) in over six countries (France, Germany, Italy, Spain, Netherlands and Belgium), the group employs 54,000 people and generated a revenue of c. €3.3bn in 2018.
This is the second transaction Clearwater has worked on involving 5 Santé, having previously advised the 5 Santé Group on financing for the acquisition of the Gustav Zander centre, a clinic specialised in follow-up care and rehabilitation, located in Aix-les-Bains.
